Michael Liang

Partner, U.S. Venture Capital - Healthcare · Baird Capital

Michael Liang, Partner at Baird Capital, invests in early- to expansion-stage healthcare companies, with a typical check size of

00K–$5.0M and a sweet spot around

.5M, focusing on sectors including medical devices, life sciences, digital health, health IT, and biotechnology[2][3]. His notable portfolio includes Alto Neuroscience, Greenlight Biosciences, OncoHealth, Amphora Medical, and Jumpco…

Stages: Pre-Seed, Seed, Series A
Focus: Healthcare

Browse all investors · Browse founders